Changes in high-rank­ing ex­ecs poised to deep­en at Karyopharm; Till­man Gern­gross-chaired biotech pro­motes new med­ical chief to CEO

→ Round and round the ex­ec­u­tive carousel turns at Karyopharm as Resh­ma Rang­wala re­places Jatin Shah as CMO, a month re­moved from the FDA pulling the rug out from un­der se­linex­or’s chances in en­dome­tri­al can­cer by call­ing for a new tri­al first. The rem­nants of the old guard at Karyopharm con­tin­ue to peel off, with co-founder and CSO Sharon Shacham now step­ping down along­side se­nior clin­i­cal ad­vi­sor and ex-CEO Michael Kauff­man start­ing May 31.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.